 
| Mime-Version: |
1.0 (Mac OS X Mail 12.4 \(3445.104.11\)) |
| Content-Type: |
text/plain; charset=utf-8 |
| Date: |
Mon, 16 Mar 2020 22:17:55 -0400 |
| Reply-To: |
|
| Subject: |
|
| From: |
|
| Message-ID: |
|
| In-Reply-To: |
|
| Content-Transfer-Encoding: |
quoted-printable |
| Sender: |
|
| Parts/Attachments: |
|
|
It boggles the mind that a region as big as EU can have treatments approved that are not automatically available in the US. My cousin in Poland has just asked me about our use of Oxybee and VarroMed in the States in the spring and I’m like, what?! I understand there are concerns, but we already have processes in place in recognizing medical & research diplomas between US and EU. Wouldn’t it have been better to extend those to certain categories of animal treatments? Is FDA really expecting to find something that EU’s certification & registration process has missed?!
Przemek
> On Mar 16, 2020, at 7:30 PM, Georges Prigent <[log in to unmask]> wrote:
>
> "In Europe, many beekeepers have switched to using glycerin rather than sugar as the humectant for the dribble."
>
> We will soon perhaps when the new formulations will be registered.
>
> Registered (most dated 2016) medications in Europe are still mainly based upon sugar solution as humectant
> Oxuvar, Andermatt Biovet Switzerland, https://www.biovet.ch/fr_bv/abeilles.html#isPage=1
> Oxybee, Dany Bienenwohl GmbH Germany
> Apibioxal, Chemicals Laif Italy https://www.alveis.it/it/api-bioxal/
> and even VarroMed, https://www.beevital.com/products#varromed-1
***********************************************
The BEE-L mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|
